联邦制药拟配股融资超22亿港元;三星医疗签订3.41亿元海外经营合同丨医药早参

每日经济新闻
Jul 22, 2025

NO.1 维康药业:维生素K1滴剂上市申请获受理不会影响近期业绩  7月21日,维康药业发布股票交易异动公告称,经自查,公司不存在违反信息公平披露的情形;公司获得维生素K1滴剂上市申请受理通知书,对公司近期业绩不会产生影响,相关药品的注册批件取得时间和结果均具有不确定性。  点评:维康药业维生素K1滴剂上市申请获受理,虽短期难改业绩,但为产品线添潜力,后续需关注注册进展及市场拓展情况。  NO.2...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10